Skip to main navigation
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
VectivBio

VectivBio

Transforming Lives

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Extraordinary General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers

SEC Filings

Filing date Form Description Filing Group View
Apr 7, 2022 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
0001628280-22-008724.pdf
0001628280-22-008724.rtf
0001628280-22-008724.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 19, 2023 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
0000950170-23-013373.pdf
0000950170-23-013373.rtf
0000950170-23-013373.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 9, 2021 424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
0001628280-21-006745.pdf
0001628280-21-006745.rtf
0001628280-21-006745.xls
View HTML
Jun 14, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
0001628280-22-017122.pdf
0001628280-22-017122.rtf
0001628280-22-017122.xls
View HTML
Jun 16, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
0001628280-22-017293.pdf
0001628280-22-017293.rtf
0001628280-22-017293.xls
View HTML
Oct 14, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
0001193125-22-262921.pdf
0001193125-22-262921.rtf
0001193125-22-262921.xls
View HTML
Jul 12, 2021 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001628280-21-013726.pdf
0001628280-21-013726.rtf
0001628280-21-013726.xls
View HTML
Aug 12, 2021 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001628279-21-000523.pdf
0001628279-21-000523.rtf
0001628279-21-000523.xls
View HTML
Aug 31, 2021 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001628280-21-017820.pdf
0001628280-21-017820.rtf
0001628280-21-017820.xls
View HTML
Sep 3, 2021 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
0001628280-21-018051.pdf
0001628280-21-018051.rtf
0001628280-21-018051.xls
View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

Primary Sidebar

INVESTORS & MEDIA

  • Overview
  • News & Media
    • Press Releases
  • Events & Presentations
  • Annual General Meeting
  • Extraordinary General Meeting
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Stock Information
    • Historical Stock Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board Members
    • Committee Composition
  • Shareholder Resources
    • FAQs
    • Email Alerts
    • Contact IR
    • RSS Feeds

Site - Shareholder Tools

Email Alerts Print Search

IR CONTACT

ir@vectivbio.com

 

Footer

Site - Footer Menu Left

VectivBio

Site - Footer Menu Center

Terms of Use Privacy Policy

Copyright © VectivBio AG, 2023. All Rights Reserved.

Site - Footer Menu Right

  • About Us
  • Our Focus
  • Investors & Media
  • Contact Us

Site - Header Menu

  • About Us
    • Management Team
    • Board Members
    • Investors
    • Partners
  • Our Focus
    • Our Science
    • Our Pipeline
    • Our Clinical Trials
  • Investors & Media
    • Overview
    • News & Media
    • Events & Presentations
    • Annual General Meeting
    • Extraordinary General Meeting
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Contact Us
    • Careers